"The University of Miami Health System combines patient care, research, and education to create a front-line approach to health care."

During the past decade, University of Miami Hospital conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 53 clinical trials were completed, i.e. on average, 47.7% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 40 clinical trials were completed. i.e. 81.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami Hospital" #1 sponsor was "University of Miami" with 19 trials, followed by "Pfizer" with 15 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 101 different institutions and companies that sponsored additional 94 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "United States Department of Defense" with 3 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "University of Alabama at Birmingham" with 2 trials as a collaborator and "ABX CRO" with 1 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami Hospital" are "COVID-19" (6 trials), "Crohn's Disease" (4 trials), "Parkinson Disease" (4 trials), "Cystic Fibrosis" (3 trials) and "Ischemic Stroke" (3 trials). Many other conditions were trialed in "University of Miami Hospital" in a lesser frequency.

Most popular intervention types in "University of Miami Hospital" are "Drug" (78 trials), "Device" (37 trials), "Other" (25 trials), "Biological" (24 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Cyclophosphamide" (3 trials), "Dexamethasone" (3 trials), "Fludarabine" (3 trials) and "Deep Brain Stimulation" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami Hospital" are 148 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Miami Hospital". undefined are not yet recruiting, 31 are recruiting, 16 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 62 completed trials in University of Miami Hospital, 3 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami Hospital, 13 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 37 trials that are defined as “Not Applicable".

University of Miami Hospital has several departments that took part in Clinical trials: "UM Sylvester Comprehensive Cancer Center at Aventura" - 14 trials